STEPHENS INC /AR/ - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$68,788
-45.4%
1,148
-34.3%
0.00%
-50.0%
Q2 2023$126,031
-4.2%
1,748
-2.2%
0.00%
-33.3%
Q1 2023$131,525
+10.4%
1,788
+0.3%
0.00%
+50.0%
Q4 2022$119,104
-22.7%
1,7830.0%0.00%
-33.3%
Q3 2022$154,000
-5.5%
1,783
-2.6%
0.00%0.0%
Q2 2022$163,000
-23.1%
1,831
-2.9%
0.00%0.0%
Q1 2022$212,000
-35.2%
1,886
-11.0%
0.00%
-40.0%
Q4 2021$327,000
+15.1%
2,120
+3.9%
0.01%
+25.0%
Q3 2021$284,000
+11.4%
2,040
+4.9%
0.00%0.0%
Q2 2021$255,000
-12.4%
1,945
+2.0%
0.00%
-20.0%
Q1 2021$291,000
-19.2%
1,906
-47.3%
0.01%
-16.7%
Q4 2020$360,000
+11.1%
3,615
+6.2%
0.01%0.0%
Q3 2020$324,000
-12.4%
3,404
+2.9%
0.01%
-25.0%
Q2 2020$370,000
-79.7%
3,307
-86.8%
0.01%
-83.3%
Q1 2020$1,821,000
-33.0%
25,042
-3.9%
0.05%
-15.8%
Q4 2019$2,718,000
-0.5%
26,063
-5.0%
0.06%
-5.0%
Q3 2019$2,731,000
-16.8%
27,433
-4.6%
0.06%
-18.9%
Q2 2019$3,282,000
-48.0%
28,755
-42.7%
0.07%
-50.7%
Q1 2019$6,309,000
+1614.4%
50,189
+1750.6%
0.15%
+1400.0%
Q4 2018$368,000
-25.7%
2,712
+50.5%
0.01%
-16.7%
Q3 2018$495,000
+124.0%
1,802
-1.0%
0.01%
+50.0%
Q2 2017$221,000
+29.2%
1,821
+13.0%
0.01%
+33.3%
Q1 2017$171,000
+69.3%
1,611
+62.6%
0.01%
+50.0%
Q4 2016$101,000
+23.2%
991
+23.7%
0.00%0.0%
Q3 2016$82,000
-2.4%
801
+14.3%
0.00%0.0%
Q2 2016$84,000
+31.2%
701
+17.0%
0.00%
+33.3%
Q1 2016$64,000
-1.5%
5990.0%0.00%0.0%
Q4 2015$65,000
+35.4%
599
+6.2%
0.00%
+50.0%
Q3 2015$48,000
-15.8%
5640.0%0.00%
-33.3%
Q2 2015$57,000
+32.6%
5640.0%0.00%
+50.0%
Q1 2015$43,000
+72.0%
564
+20.0%
0.00%
+100.0%
Q4 2014$25,000
+8.7%
470
-5.6%
0.00%0.0%
Q3 2014$23,000
+4.5%
498
+38.7%
0.00%0.0%
Q2 2014$22,000
+29.4%
359
+41.3%
0.00%0.0%
Q1 2014$17,000
+41.7%
254
+8.1%
0.00%0.0%
Q4 2013$12,000
+50.0%
235
+23.7%
0.00%
Q3 2013$8,0001900.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders